Author

D. C. Adelsberg

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 2 Assay:proteomics· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1 Assay:structural biology· 1

Frequent Co-Authors

G. Bajic· 3 shared F. Amanat· 2 shared F. Krammer· 2 shared A. C. M. Boon· 1 shared A. Ellebedy· 1 shared A. H. Ellebedy· 1 shared A. J. Schmitz· 1 shared A. Joshi· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

G. Bajic

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintApr 20, 2023

An in vitro experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodies

K. E. Atanasoff, L. Brambilla, D. C. Adelsberg…·D. Tortorella

This paper characterizes the binding specificity and epitope of a broadly neutralizing anti-SARS-CoV-2 Spike RBD antibody using mAb-resistant virions and cryo-EM structural analysis.

DOI 10.1101/2023.04.20.537738

virusproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintJul 8, 2021

Structure of a germline-like human antibody defines a neutralizing epitope on the SARS-CoV-2 spike NTD

C. G. Altomare, D. C. Adelsberg, J. M. Carreno…·G. Bajic

The paper structures a germline-like antibody in complex with SARS-CoV-2 spike NTD, revealing a neutralizing epitope and its conservation across variants.

DOI 10.1101/2021.07.08.451649

humanstructural biology

𝕏 PostBluesky

ImmunologybioRxivMar 24, 2021

A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants

A. J. Schmitz, J. S. Turner, Z. Liu…·A. H. Ellebedy

A vaccine-induced human monoclonal antibody neutralizes SARS-CoV-2 and variants, reducing lung inflammation and viral load in hamsters.

DOI 10.1016/j.immuni.2021.08.013

humanproteomics

𝕏 PostBluesky